Skip to main content
. Author manuscript; available in PMC: 2022 Sep 1.
Published in final edited form as: Neurosci Biobehav Rev. 2021 Jun 29;128:358–366. doi: 10.1016/j.neubiorev.2021.06.038

Table 1.

This table summarizes the studies that have examined the role of ovarian hormones in preclinical models of cocaine and opioid use disorder. The rows for each drug reflect changes to behavioral phenotypes following OVX and OVX + estradiol replacement. The line symbolizes that no studies have examined this directly.


OVX

CPP Self-administration Seeking PR Responding
Cocaine -
Opioids ↓, ↑ No effect No effect No effect

OVX + estradiol replacement

CPP Self-administration Seeking PR Responding

Cocaine
Opioids ↑, No effect ↑, No effect ↓, No effect No effect

This table summarizes the studies that have examined the role of ovarian hormones in preclinical models of cocaine and opioid use disorder. The rows for each drug reflect changes to behavioral phenotypes following OVX and OVX + estradiol replacement. The line symbolizesthat no studies have examined this directly